Cost-effectiveness of magnetic resonance guided focused ultrasound for the treatment of uterine fibroids

International Journal of Technology Assessment in Health Care

Volumn 25, Issue 1, 2009, Pages 14-25

  O'Sullivan, Amy K ^a   Thompson, David ^a   Chu, Paula ^a   Lee, David W ^b   Stewart, Elizabeth A ^c   Weinstein, Milton C ^d  

^a i3 Global   (Canada)

^b Health Economics and Outcomes Research   (United States)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cost effectiveness; Markov model; Uterine fibroids

Indexed keywords

CASE ANALYSIS; DECISION ANALYSIS; ECONOMIC MODELS; FOCUSED ULTRASOUND; INCREMENTAL COST; MARKOV MODEL; PHARMACOTHERAPIES; PREMENOPAUSAL WOMEN; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; TOTAL COSTS; UTERINE ARTERY EMBOLIZATION; UTERINE FIBROIDS;

ACOUSTIC WAVES; COST EFFECTIVENESS; COSTS; DECISION MAKING; DECISION THEORY; MAGNETIC RESONANCE; MARKOV PROCESSES; SENSITIVITY ANALYSIS; ULTRASONICS;

COST BENEFIT ANALYSIS;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER SCREENING; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; LIFESPAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PREMENOPAUSE; PRODUCTIVITY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RECURRENT DISEASE; SENSITIVITY ANALYSIS; UNITED STATES; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; INSTRUMENTATION; LEIOMYOMA; ORGANIZATION AND MANAGEMENT; PROBABILITY; STATISTICAL MODEL;

COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; EFFICIENCY; EFFICIENCY, ORGANIZATIONAL; FEMALE; HEALTH EXPENDITURES; HUMANS; LEIOMYOMA; MAGNETIC RESONANCE IMAGING; MARKOV CHAINS; MODELS, ECONOMIC; MODELS, STATISTICAL; UNITED STATES;

EID: 60749085912     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462309090035     Document Type: Article

References (43)

1. Agency for Healthcare Research and Quality (AHRQ). Evidence Report No. 34. Management of uterine fibroids volume1. January 2001. http://www.ncbi.nlm. nih.gov/books/bv.fcgi?rid=hstat1.chapter.47755. Accessed April 5, 2006.
2. American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin. Number 16. Surgical alternatives to hysterectomy in the management of leiomyomas. Washington, DC: American College of Obstetricians and Gynecologists; 2000.
3. Arleo EK, Khilnani NM, Ng A, Min RJ. Features influencing patient selection for fibroid treatment with magnetic resonance-guided focused ultrasound. J Vasc Interv Radiol. 2007;18:681-685. (Pubitemid 46661176)
4. Beinfeld MT, Bosch JL, Gazelle GS. Hospital costs of uterine artery embolization and hysterectomy for uterine fibroid tumors. Acad Radiol. 2002;9:1300-1304. (Pubitemid 35265401)
5. Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS. Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology. 2004;230:207-213. (Pubitemid 37549803)
6. Blue Cross and Blue Shield Association (BCBS). Uterine artery embolization for treatment of symptomatic uterine fibroids. 2002;17:1-20. http://www.ahrq.gov/clinic/epcsums/ utersumm.htm.
7. Brahma PK, Martel KM, Christman GM. Future directions in myoma research. Obstet Gynecol Clin. 2006;33:199-244.
8. Carls GS, Lee DW, Ozminkowski RJ, et al. What are the total costs of surgical treatment for uterine fibroids? J Womens Health. 2008;17:1119-1132.
9. Cura M, Cura A, Bugnone A. Role of magnetic resonance imaging in patient selection for uterine artery embolization. Acta Radiol. 2006;47:1105-1114. (Pubitemid 44838074)
10. Dembek CJ, Pelletier EM, Isaacson KB, Spies JB. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids. J Vasc Interv Radiol. 2007;18:1207-1213. (Pubitemid 47446274)
11. Dicker RC, Greenspan JR, Strauss LT, et al. Complications of abdominal and vaginal hysterectomy among women of reproductive age in the United States: The collaborative review of sterilization. Am J Obstret Gynecol. 1982;144:841-848.
12. Drug Topics Redbook 2006. Montvale NJ: Thompson PDR; 2006.
13. Ecker JL, Foster JT, Friedman AJ. Abdominal hysterectomy or abdominal myomectomy for symptomatic leiomyoma: A comparison of preoperative demography and postoperative morbidity. J Gynecol Surg. 1995;11:11-18.
14. Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging-guided focused ultrasound surgery-Results of different treatment protocols. Radiology. 2007;243:885-893.
15. Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195:955-964. (Pubitemid 44415640)
16. Gavrilova-Jordan LP, Rose CH, Traynor KD, et al. Successful term pregnancy following MR-guided focused ultrasound treatment of uterine leiomyoma. J Perinatol. 2007;27:59-61. (Pubitemid 44971055)
17. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Costeffectiveness in health and medicine. New York, NY: Oxford University Press, Inc; 1996.
18. Goldberg J, Bussard A, McNeil J, Diamond J. Cost and reimbursement for three fibroid treatments: Abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization. Cardiovasc Intervent Radiol. 2007;30:54-58. (Pubitemid 44900490)
19. Gupta J, Sinha A, Lumsden M, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2006;1:CD005073.
20. Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006;108:930-937. (Pubitemid 44498255)
21. Hesley GK, Felmlee JP, Gebhart JB, et al. Noninvasive treatment of uterine fibroids: Early Mayo experience with magnetic resonance imaging-guided focused ultrasound. Mayo Clin Proc 2006;81:936-942.
22. InSightec. Report to the FDA, December 2006. www.insightec.com/SIP- STORAGE/files/9/349.pdf.
23. Iverson RE Jr, Chelmow D, Strohbehn K, et al. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol. 1996;88:415-419. (Pubitemid 26293290)
24. Mauskopf J, Flynn M, Thieda P, et al. The economic impact of uterine fibroids in the United States: A summary of published estimates. J Womens Health. 2005;14:692-703. (Pubitemid 41645631)
25. Morita Y, Ito N, Ohashi H. Pregnancy following MR-guided focused ultrasound surgery for a uterine fibroid. Int J Gynaecol Obstet. 2007;99:56-57. (Pubitemid 47347998)
26. Oderda G, Asche C, JonesKP, et al. Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid. Arch Gynecol Obstet. 2007;276:211-218. (Pubitemid 47125084)
27. Pelage JP, Le Dref O, Soyer P, et al. Fibroid-related menorrhagia: Treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000;215:428-431. (Pubitemid 30237840)
28. Rannestad T. Hysterectomy: Effects on quality of life and psychological aspects. Best Pract Res Clin Obstet Gynaecol. 2005;19:419-430. (Pubitemid 40873503)
29. Reed SD, Newton KM, Thompson LB, et al. The incidence of repeat uterine surgery following myomectomy. J Womens Health. 2006;15:1046-1052. (Pubitemid 46381778)
30. Smart OC, Hindley JT, Regan L, Gedroyc W. Gonadotrophinreleasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol. 2006;108:49-54. (Pubitemid 44336844)
31. Smith SJ. Uterine fibroid embolization. Am Fam Physician. 2000;61:3601-3607.
32. Spies JB, Ascher SA, Roth AR, et al. Uterine artery embolization for leiomyomata. Obstet Gynecol. 2001;98:29-34.
33. Spies JB, Bruno J, Czeyda-Pommersheim F, et al. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol. 2005;106:933-939. (Pubitemid 41532897)
34. Spies JB, Cooper JM, Worthington-Kirsch R, et al. Outcome of uterine embolization and hysterectomy for leiomyomas: Results of a multicenter study. Am J Obstet Gynecol. 2004;191:22-31. (Pubitemid 39077952)
35. Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110:279-287. (Pubitemid 47356651)
36. Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85:22-29. (Pubitemid 43063413)
37. Subramanian S, Clark MA, Isaacson K. Outcome and resource use associated with myomectomy. Obstet Gynecol. 2001;98:583-587. (Pubitemid 32907450)
38. Sullivan PW, Lawrence WF, Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006;26:410-420. (Pubitemid 44050845)
39. Toaff ME. Why would a woman resist hysterectomy. http://althysterectomy. org/. Accessed May 2007.
40. U.S. Bureau of Labor Statistics. UsualWeekly Earnings of Wage and Salary Workers: First Quarter 2006. http://www.bls.gov/news.release/archives/wkyeng- 04202006.pdf. Accessed September 2006.
41. Volkers NA, Hehenkamp WJK, Birnie E, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. Am J Obstet Gynecol. 2007;196:519e1- 519e11. (Pubitemid 46836620)
42. Walker CL, Stewart EA. Uterine fibroids: The elephant in the room. Science 2005;308:1589-1592.
43. Zowall H, Carins JA, Brewer C, et al. Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for the treatment of uterine fibroids. BJOG. 2008;115:653-662. (Pubitemid 351357573)